EU regulator backs Bayer, GSK drugs, knocks back Novartis, Teva

January 24, 2014 1:01 PM

7 0

EU regulator backs Bayer, GSK drugs, knocks back Novartis, Teva

LONDON (Reuters) - Europe's drugs regulator gave its backing on Friday for marketing approval to be granted for Bayer's pulmonary hypertension drug Adempas and for GlaxoSmithKline's diabetes medicine Eperzan.

The European Medicine Agency (EMA) also backed a new drug from Dainippon Sumitomo Pharma called Latuda, for the treatment of schizophrenia, and Bemfola, a new biosimilar medicine for the treatment of infertility.

Read more

To category page

Loading...